Toripalimab Combined With FLOT Neoadjuvant Chemotherapy in Patients With Resectable Gastric Cancer
Clinical trial NCT04354662 · COMPLETED
Trial details
- NCT number
- NCT04354662
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-25
- Primary completion
- 2022-08-31
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.